| Literature DB >> 17229325 |
Deborah J Toobert1, Russell E Glasgow, Lisa A Strycker, Manuel Barrera, Debra P Ritzwoller, Gerdi Weidner.
Abstract
BACKGROUND: Multiple-risk-factor interventions offer a promising means for addressing the complex interactions between lifestyle behaviors, psychosocial factors, and the social environment. This report examines the long-term effects of a multiple-risk-factor intervention.Entities:
Year: 2007 PMID: 17229325 PMCID: PMC1783667 DOI: 10.1186/1479-5868-4-1
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Figure 17-Day Self-Monitoring Chart.
Characteristics of participants by treatment condition
| Mean (SD) or Percent | |||
| Characteristic | Usual Care (N = 116) | MLP ( | Significance ( |
| Age | 60.7 (7.8) | 61.1 (8.0) | .70 |
| Weight (kg) | 93.9 (23.8) | 92.3 (21.2) | .55 |
| Waist/hip ratio | 0.9 (.08) | 0.91 (.08) | .35 |
| Body mass index (kg/m2) | 35.6 (8.8) | 35.1 (7.7) | .62 |
| Age diagnosed with diabetes | 52.5 (10.7) | 53.0 (10.0) | .71 |
| Years taking medications | 5.0 (6.3) | 4.9 (4.9) | .90 |
| Years diagnosed with diabetes | 8.5 (8.3) | 8.2 (7.3) | .77 |
| Current smoker (% yes) | 10.3 | 8.7 | .59 |
| Income | .22 | ||
| % $0 to $ 9,999 | 14.9 | 5.8 | |
| % $10,000 to $19,999 | 21.9 | 24.5 | |
| % $20,000 to $29.999 | 17.5 | 23.9 | |
| % $30,000 to $39,000 | 17.5 | 14.2 | |
| % $40,000 to $49,000 | 10.5 | 11.0 | |
| % $50,000 to $59,999 | 9.5 | 5.8 | |
| % $60,000 to $69,999 | 0.9 | 5.2 | |
| % $70,000 to $79,999 | 1.7 | 3.9 | |
| % $80,000 or more | 5.2 | 5.8 | |
| Type of glucose-lowering medication | .62 | ||
| % None | 17.2 | 24.7 | |
| % Oral medication only | 61.2 | 54.9 | |
| % Insulin only | 12.1 | 7.4 | |
| % Insulin and oral medication | 9.5 | 13.0 | |
| Present living arrangement | .43 | ||
| % With spouse | 49.1 | 51.5 | |
| % With spouse and children | 11.2 | 9.8 | |
| % With children or others | 9.4 | 14.7 | |
| % Alone | 30.2 | 23.9 | |
| Level of education achieved | .72 | ||
| % 0 to 11th grade | 11.2 | 8.5 | |
| % High school graduate | 25.0 | 25.2 | |
| % Some college | 39.7 | 43.6 | |
| % College/university graduate | 24.1 | 22.7 | |
| % Caucasian | 94.8 | 92.0 | .59 |
| Medications | |||
| % Taking lipid-lowering | 40.5 | 38.9 | .79 |
| % Taking blood pressure-lowering | 47.4 | 46.3 | .86 |
| % Taking estrogen replacement therapy | 46.6 | 59.3 | .04 |
| Number of comorbidities | .27 | ||
| % With no other disease | 4.3 | 4.9 | |
| % With 1–2 other diseases | 43.1 | 50.9 | |
| % With ≥ 3 other diseases | 52.6 | 44.2 | |
| Most prevalent comorbidities | |||
| % Having CHD | 15.0 | 14.0 | .26 |
| % Having arthritis | 50.9 | 56.4 | .36 |
| % Having high blood pressure | 72.4 | 70.6 | .74 |
| % Having back problems | 37.9 | 33.1 | .41 |
Behavioral outcomes for usual care (UC) and intervention (MLP) conditions at baseline, and 6, 12, and 24 months
| Baseline Mean (SD) | 6 months Mean (SD) | 12 months Mean (SD) | 24 months Mean (SD) | Between subjects | Condition by time | |
| Diet (% calories saturated fat) | ||||||
| UC | .13 (.04) | .12 (.04) | .12 (.04) | .12 (.04) | 39.30*** | 2.74 |
| MLP | .14 (.03) | .10 (.03) | .11 (.03) | .11 (.03) | ||
| Physical Activity (kcal/kg/hr moderate activity) | ||||||
| UC | 7.72 (8.44) | 7.56 (6.66) | 6.39 (6.73) | 7.13 (5.29) | 7.62 ** | .11 |
| MLP | 5.63 (5.30) | 8.78 (6.51) | 7.69 (6.35) | 7.90 (6.55) | ||
| Daily Practice (minutes) | ||||||
| UC | 10.3 (19.8) | 11.7 (19.4) | 9.4 (20.5) | 11.0 (19.2) | 20.48*** | 0.94 |
| MLP | 6.1 (14.0) | 20.8 (17.4) | 16.0 (16.5) | 16.8 (16.4) | ||
| Flexibility (sit-and-reach % score) | ||||||
| UC | 32.9 (25.7) | 31.0 (27.2) | 28.6 (28.3) | 30.4 (28.4) | 3.99* | 0.32 |
| MLP | 32.3 (23.9) | 36.2 (27.3) | 32.2 (28.6) | 36.2 (29.0) | ||
| Flexibility (range-of-motion % score) | ||||||
| UC | 10.8 (21.2) | 9.5 (19.6) | 6.4 (16.7) | 9.8 (22.4) | ||
| MLP | 14.7 (24.1) | 15.2 (24.9) | 14.7 (25.1) | 14.4 (25.9) | ||
Note: Baseline values, social desirability, income, age, and comorbidities were entered as covariates. Based on repeated measures MANCOVAs (and follow-up ANOVAs) using complete cases (N = 118 for CHAMPS; N = 192 for all other analyses). Means are not adjusted for baseline levels or covariates. * = p < .05; ** = p < .01; *** = p < .001.
Psychosocial outcomes for usual care (UC) and intervention (MLP) conditions at baseline, and 6, 12, and 24 months
| Baseline Mean (SD) | 6 months Mean (SD) | 12 months Mean (SD) | 24 months Mean (SD) | Between subjects | Condition by time | |
| UCLA Negative Summary Score | ||||||
| UC | 3.95 (.46) | 3.99 (.53) | 4.03 (.47) | 3.99 (.53) | 3.98* | 1.48 |
| MLP | 3.98 (.45) | 3.91 (.54) | 3.92 (.53) | 3.99 (.53) | ||
| UCLA Positive Summary Score | ||||||
| UC | 2.95 (.60) | 2.99 (.71) | 3.00 (.77) | 2.99 (.71) | 30.11*** | 2.96a |
| MLP | 2.85 (.73) | 3.40 (.74) | 3.28 (.74) | 3.20 (.79) | ||
| Chronic Illness Resources Survey | ||||||
| UC | 2.77 (.55) | 2.77 (.59) | 2.77 (.60) | 2.78 (.58) | 5.76* | 1.47 |
| MLP | 2.69 (.58) | 2.92 (.65) | 2.84 (.52) | 2.80 (.56) | ||
| Confidence to Overcome Challenges | ||||||
| UC | 3.1 (.73) | 3.0 (.79) | 3.0 (.78) | 2.9 (.76) | 11.43*** | .47 |
| MLP | 3.0 (.77) | 3.1 (.73) | 3.1 (.77) | 3.1 (.81) | ||
| Sallis Self-Efficacy for Diet and Exercise | ||||||
| UC | 4.1 (.58) | 3.8 (.71) | 3.9 (.71) | 3.8 (.66) | 14.51*** | 1.33 |
| MLP | 4.1 (.59) | 4.1 (.54) | 4.0 (.59) | 4.1 (.62) | ||
| UC | 3.6 (.68) | 3.6 (.78) | 3.9 (.70) | 3.8 (.68) | 11.73*** | 1.35 |
| MLP | 3.6 (.77) | 3.9 (.77) | 4.1 (.67) | 4.0 (.72) | ||
| UC | 15 (10) | 15 (12) | 14 (9) | 14 (10) | 0.34 | 2.33 |
| MLP | 12 (11) | 13 (11) | 15 (11) | 12 (11) | ||
| UC | 2.7 (.57) | 2.6 (.59) | 2.6 (.58) | 2.6 (.61) | 0.90 | 3.70* |
| MLP | 2.6 (.63) | 2.5 (.62) | 2.6 (.66) | 2.4 (.64) | ||
| UC | 1.59 (.43) | 1.60 (.47) | 1.59 (.49) | 1.58 (.44) | 1.59 | .36 |
| MLP | 1.58 (.38) | 1.52 (.36) | 1.55 (.47) | 1.52 (.44) | ||
| Regimen-Related Scale | ||||||
| UC | 17.9 (5.8) | 15.7 (5.2) | 15.5 (5.6) | 15.2 (5.2) | 3.45a | 1.03 |
| MLP | 18.7 (5.3) | 14.8 (4.7) | 15.1 (4.6) | 15.0 (4.9) | ||
| Interpersonal Distress Scale | ||||||
| UC | 12.5 (5.0) | 11.2 (4.4) | 11.2 (4.5) | 10.6 (3.7) | 1.13 | .21 |
| MLP | 12.8 (4.9) | 11.7 (4.4) | 11.5 (4.9) | 11.2 (4.6) | ||
Note. Baseline values and social desirability were entered as covariates. Based on repeated measures MANCOVAs (and follow-up ANOVAs) using complete cases (Ns ranged from 194 for Self-monitored stress to 204 for most of the other measures). Means are not adjusted for baseline levels or covariates. * = p < .05; ** = p < .01; *** = p < .001; a = p < .1.